CAS 1446790-62-0

Formule : C18H25N7O

InChI : InChI=1S/C18H25N7O/c1-10-7-8-15(21-11(10)2)23-14-9-16(24-25-17(14)18(20)26)22-13-6-4-3-5-12(13)19/h7-9,12-13H,3-6,19H2,1-2H3,(H2,20,26)(H2,21,22,23,24)/t12-,13+/m0/s1

Code InChI : XJZVCDVZCRLIKN-QWHCGFSZSA-N

SMILES : CC1=C(N=C(C=C1)NC2=CC(=NN=C2C(=O)N)N[C@@H]3CCCC[C@@H]3N)C

RO9021

CAS : 1446790-62-0

RO9021

Formule : C₁₈H₂₅N₇O

Degré de pureté : ≥95%

Masse moléculaire : 355.44

Ref: 54-BUP09607

RO9021

CAS : 1446790-62-0

Formule : C₁₈H₂₅N₇O

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 355.4374

Ref: IN-DA00ABT7

RO9021

CAS : 1446790-62-0

6-(((1R,2S)-2-Aminocyclohexyl)amino)-4-((5,6-dimethylpyridin-2-yl)amino)pyridazine-3-carboxamide

Formule : C₁₈H₂₅N₇O

Degré de pureté : 98%

Masse moléculaire : 355.44

Ref: IN-DG764784

RO9021

CAS : 1446790-62-0

RO9021 is a synthetic peptide, which is derived from bacterial lipoproteins, with a mechanism of action that targets and modulates specific inflammatory pathways. This peptide interacts with cell surface receptors, such as Toll-like receptors (TLRs), to inhibit the signaling cascades that lead to the production of pro-inflammatory cytokines. By acting on these crucial pathways, RO9021 effectively reduces inflammation and can modulate immune responses.

Formule : C₁₈H₂₅N₇O

Degré de pureté : Min. 95%

Masse moléculaire : 355.44 g/mol

Ref: 3D-WHC79062

RO9021

CAS : 1446790-62-0

RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM).

Formule : C₁₈H₂₅N₇O

Degré de pureté : 99.90%

Couleur et forme : Solid

Masse moléculaire : 355.4374

Ref: TM-T16776